OneDigital Investment Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$424K Sell
5,345
-45
-0.8% -$3.39K ﹤0.01% 1112
2026
Q1
$405K Buy
5,390
+384
+8% +$30.3K ﹤0.01% 1030
2025
Q4
$396K Buy
5,006
+1,418
+40% +$107K ﹤0.01% 1062
2025
Q3
$235K Buy
+3,588
New +$175K ﹤0.01% 1341
2019
Q3
Sell
-1,500
Closed -$96K 849
2019
Q2
$96K Buy
+1,500
New +$106K 0.01% 466

Other funds holding IONS

OneDigital Investment Advisors's IONS Position: Q2 2026 in Review

OneDigital Investment Advisors reduced its Ionis Pharmaceuticals (IONS) stake by 0.83% in Q2 2026, selling an estimated $3.39K and leaving 5,345 shares worth $424K. The position accounts for ﹤0.01% of the portfolio, ranked #1112.

OneDigital Investment Advisors first reported a position in IONS in Q2 2019 and has held it in 5 quarters since. 283 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • OneDigital Investment Advisors held 5,345 shares of Ionis Pharmaceuticals worth $424K as of Q2 2026.
  • OneDigital Investment Advisors sold 45 Ionis Pharmaceuticals shares in Q2 2026, an estimated $3.39K.
  • Ionis Pharmaceuticals made up ﹤0.01% of OneDigital Investment Advisors's portfolio in Q2 2026, its #1112 holding.
  • OneDigital Investment Advisors first reported a position in Ionis Pharmaceuticals in Q2 2019 and has held it in 5 quarters since.
  • 283 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on OneDigital Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.